Severe PTSD characterized by lower oxytocin and higher vasopressin levels

Research finds PTSD marked by reduced oxytocin and elevated vasopressin, suggesting AVP/OT ratios as potential biomarkers for diagnosis and treatment response.

FDA advisors unanimously reject Intarcia’s embattled type 2 diabetes treatment

I2o Therapeutics CEO Kurt Graves set out on Thursday to make a case to a panel of the FDA’s expert advisors that the benefits of

September 23, 2023

Alumis secures $259m to develop therapies for immune dysfunction

Share this article The funding will enable the development of Alumis’ data analytics and multi-platform approach to investigate ESK-001 for other autoimmune diseases. Credit: Mongkolchon

March 7, 2024

Opinion | In the Marrow of My Bones

Solomon is a certified nurse-midwife and a retired psychiatric NP. I forget his name, nothing else. He was gorgeous, for starters. Tall, slim. Not too

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.